sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M. Smadja, France Mentré, Sophie Luneau et al.|Scientific Reports|2025Cited by 7
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I InterferonsAstrid Marchal, Charles Cazanave, Thibault Kerdiles et al.|The Journal of Infectious Diseases|2026Cited by 0